Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Celgene Corp (CELG)’

Activist Keith Meister Says This Year’s Market Rally and Last December’s Sell-Off Made Us Break Even

In a yesterdays’ CNBC “Squawk Box” program, Corvex Management’s Keith Meister was a guest and he shared his views on the current and the future......(read more)
Covalis Capital's Returns, AUM and Holdings

Hedge Fund and Insider Trading News: Seth Klarman, John Paulson, Ray Dalio, Elliott Management, Starboard Value, HD Supply Holdings Inc (HDS), CBAK Energy Technology Inc (CBAT), and a lot More

Billionaire Hedge Fund Manager Klarman Issues Dire Warning on Global Economy (CNBC) Seth Klarman, a hedge fund billionaire some call the next Warren Buffett......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Rock Springs Capital Management’s Top 5 Largest Stock Picks

Rock Springs Capital Management is a Baltimore-based hedge fund founded in February 2013 by Kris Jenner. Prior to that, Jenner had spent  14 years working......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): Revelations From This Blazing Biotech

Blazing. Sizzling. On fire. They all describe Celgene Corporation (NASDAQ:CELG) pretty well these days. With all of the heat generated by this biotech......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Bristol-Myers Squibb Co (BMY): One Drug Dramatically Reshaping Pancreatic Cancer Treatment

A couple months may not seem like a long time, but when you’re diagnosed with pancreatic cancer, the prospect of a few months makes a huge difference......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY), Pfizer Inc. (PFE): This Biotech Has So Many Reasons to Be Liked

Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): When Will the Good News End for This Biotech?

They say that bad news comes in threes. I’m not sure if there’s a similar saying for good news, but for Celgene Corporation (NASDAQ:CELG)......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Pharmacyclics, Inc. (PCYC), Johnson & Johnson (JNJ): The FDA Loves This Drug

It should come as no surprise to anyone that the Food and Drug Administration granted a priority review for Pharmacyclics, Inc. (NASDAQ:PCYC) and Johnson......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Cytokinetics, Inc. (CYTK), Astex Pharmaceuticals, Inc. (ASTX): Is the Biotech Bubble About to Burst?

“Bubble” can be a provocative word in investing circles. Think of all that comes to mind when you hear it — perhaps other words like......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Amgen, Inc. (AMGN), AstraZeneca plc (ADR) (AZN): What’s the Big Deal About Onyx Pharmaceuticals, Inc. (ONXX) Anyway?

At the end of June, Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) announced that it had rejected an offer from Amgen, Inc. (NASDAQ:AMGN) that valued the......(read more)
Vertex Pharmaceuticals Incorporated

Exelixis, Inc. (EXEL), Vertex Pharmaceuticals Incorporated (VRTX), Celgene Corporation (CELG): Want Multibaggers? Consider These 3 Biotech Companies

In after hours trading on April 18, a few hours after the release of my previous article focusing on Exelixis, Inc. (NASDAQ:EXEL), Vertex Pharmaceuticals......(read more)
Celgene Corporation (NASDAQ:CELG)

Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): Celgene Corporation (CELG)’s Multiple Myeloma Powerhouse

Earlier this month, biotech powerhouse Celgene Corporation (NASDAQ:CELG) announced that the European Commission approved the combinational therapy of......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Pharmacyclics, Inc. (PCYC), Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): This Small Company Is Winning the War Against Blood Cancer

About 15,680 Americans are diagnosed with chronic lymphocytic leukemia, or CLL, and approximately 5,000 new cases of mantle cell lymphoma, or MCL, occur......(read more)
Incyte Corporation (NASDAQ:INCY)

Novartis AG (ADR) (NVS), Amgen, Inc. (AMGN): Incyte Corporation (INCY) Jumps on Jakafi Results

Incyte Corporation (NASDAQ:INCY) today announced positive results from a phase 2 study of its drug Jakafi in treating refractory metastatic pancreatic......(read more)
Biggest IPOs in US History

Visa Inc (V), Apple Inc. (AAPL): Capital Gains Today, Dividend Growth Tomorrow

One of the traits an investor should have is an ability to display forward-thinking. It is always better to see whats next instead of what has already......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Compugen Ltd. (USA) (CGEN): This Week in Biotech

With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc (AGIO), Heat Biologics Inc (HTBX), Cellular Dynamics International Inc (ICEL): Are These Three Recent Biotech IPOs Worth Buying?

2013 has been a banner year for biotech IPOs. Over the past two weeks, three major biotechs — Agios Pharmaceuticals Inc (NASDAQ:AGIO), Heat Biologics......(read more)
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

Celgene Corporation (CELG), Novartis AG (ADR) (NVS): Momenta Pharmaceuticals, Inc. (MNTA) Earnings Remind Investors of Growing Pains

The investing waters can get pretty choppy from time to time with a developmental stage company. A look at the five-year chart of Momenta Pharmaceuticals......(read more)
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)

3 Things You Need to Know From Astex Pharmaceuticals, Inc. (ASTX)’s Q2 Earnings

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) announced its second-quarter financial results on Thursday prior to the market open. The company reported a......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Celgene Corporation (CELG): Biotech Favorites With Noteworthy Drug Data

Three of the biggest names in biotechnology have reported earnings, and their quarters involved very important drug-related information for investors.......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Have You Considered Biotech Yet?

We are in the midst of the earnings season, my favorite time of the year. Some of the largest and most powerful publicly traded firms have already reported......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG): Has Multiple Myeloma Met its Match?

Multiple myeloma is a cancer of plasma cells, a type of white blood cell present in bone marrow. This cancer can lead to abnormally high calcium levels......(read more)
Celgene Corporation (NASDAQ:CELG)

Three Things You Need to Know From Celgene Corporation (CELG)’s Q2 Earnings

Celgene Corporation (NASDAQ:CELG) did it again. Investors have grown accustomed to the company reporting solid numbers with its earnings announcements......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN), Celgene Corporation (CELG): Is Big Biotech Still Growing?

The first half of 2013 has seen remarkable growth in the biotech sector, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) up >40% YTD......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG): Does This BiotechStudy Matter to You?

Note: This article has been amended to remove the specifics of the Questcor investigation. Motley Fool apologizes for the error. Celgene Corporation (......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG): Does This BiotechStudy Matter to You?

Celgene Corporation (NASDAQ:CELG) fell 2.6% on Thursday after disappointing clinical data for its blood cancer drug Revlimid. Investors don’t appear......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG): Expanding Labels to Expand Margins

In an industry where buyouts are commonplace and small-cap biotechs burn through cash rapidly, optimizing operating cash flow can be essential to a company......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG): Can This Biotech Go Even Higher?

Celgene Corporation (NASDAQ:CELG) has emerged as the leading treatment provider for blood cancer. The company value has almost doubled in the last year......(read more)
Celgene Corporation (NASDAQ:CELG)

What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?

Early this morning, Celgene Corporation (NASDAQ:CELG) announced that it was discontinuing the phase 3 ORIGIN Trial evaluating Revlimid (lenalidomide)......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): A Fundamentally Strong Biotech Stock

Celgene Corporation (NASDAQ:CELG) surged 7% on Thursday, July 11, 2013 on news that the Phase III trials of Revlimid /dexamethasone combination showed......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Pharmacyclics, Inc. (PCYC): Will This Be the Breakthrough of All Breakthrough Therapy Drugs?

In July 2012, the Food and Drug Administration Safety and Innovation Act was signed into law; and little did we know at the time, but the drug development......(read more)
Celgene Corporation (NASDAQ:CELG)

Revlimid Results Rev Up Celgene Corporation (CELG)

Good news seems to find its way to Celgene Corporation (NASDAQ:CELG)‘s door frequently these days. The company announced positive results today......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Who Could Buy Onyx Pharmaceuticals, Inc. (ONXX) and at What Price?

Recently Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) rejected a $10 billion takeover offer from Amgen, Inc. (NASDAQ:AMGN). However, after that it hired an......(read more)
Biogen Idec Inc (NASDAQ:BIIB)

Biogen Idec Inc. (BIIB), Celgene Corporation (CELG), Gilead Sciences, Inc. (GILD): 3 of Biotech’s Best

It’s been a healthy year-to-date for the biotech sector, with the space logging huge gains above and beyond those of the broad based market. Industry......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN), Celgene Corporation (CELG), Biogen Idec Inc. (BIIB): Watch Out for These 3 Biotech Companies

The growth of the biotechnology industry is greatly influenced by research and development expenditure. This year, the North American players in the biotechnology......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Amgen, Inc. (AMGN), Onyx Pharmaceuticals, Inc. (ONXX): Is This Biopharmaceutical Stock Still a Buy?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) has recently experienced a significant jump of nearly 51.3% in only one trading day from $86.82 per share to $......(read more)
Starbucks Corporation (NASDAQ:SBUX)

Starbucks Corporation (SBUX), Celgene Corporation (CELG), LinkedIn Corp (LNKD): Top 10 Performing Large Cap Stocks Through First Half of 2013

As the first half of 2013 ends, let’s look at the year-to-date top performing (and profitable) large cap stocks. Our goal is to identify some winners......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX) Bidding Wars: Who Would Be the Best Suitor?

A lot of activity is happening in the biotech industry which would change the dynamics of the large cancer related drug makers. Recently, Amgen, Inc. (......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX) Says the Price Isn’t Right

Sorry, Bob Barker and Drew Carey — the price isn’t right. That’s the message from Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) over the......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Ariad Pharmaceuticals, Inc. (ARIA), VIVUS, Inc. (VVUS): Winning Biotech Investment Strategies and Their Potential Pitfalls

Investing in biotech companies isn’t without its challenges, but it doesn’t have to be a shot in the dark, either. With a little bit of study......(read more)
Affymax, Inc. (NASDAQ:AFFY)

Oncolytics Biotech, Inc. (USA) (ONCY): This High-Risk, High-Reward Biotech Is Worth a Look

Let me preface this by saying that investing in the biotech sector can sometimes be nothing more than speculating. The fortunes of a biotechnology can......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Biting Into Biotechnology

Global equity markets have been rocked recently as fears of rising interest rates and tightening monetary possible make their way into the minds of the......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Amgen, Inc. (AMGN): The Only True Biotech Dividend Stock

Dividend stocks are hard to come by in the biotech space. There are plenty of pharmas that offer dividends, but finding a biotech stock that offers a......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Time to Buy Amgen, Inc. (AMGN)?

A double-digit drop for Amgen, Inc. (NASDAQ:AMGN) stock over the past couple of months has likely left a bad taste in the mouths of shareholders. Is......(read more)
Biogen Idec Inc (NASDAQ:BIIB)

Biogen Idec Inc. (BIIB), Alexion Pharmaceuticals, Inc. (ALXN): Best-Run Biotech Companies

Which biotech companies are the best-run? That could be a difficult question to answer, since there are many perspectives on what constitutes a well-run......(read more)
Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG), Halliburton Company (HAL), Starbucks Corporation (SBUX): Dividends, Schmividends

Almost all retirement investment strategies advocate generating a steady income from dividend payments from well-established, safe stocks. And while it......(read more)
Bristol Myers Squibb Co. (NYSE:BMY)

Bristol Myers Squibb Co (BMY), Momenta Pharmaceuticals, Inc. (MNTA): White Collar Criminals Love Biotech Stocks

It’s understandably very tempting for people with inside information to trade biotech stocks. With the potential for overnight doubles and triples......(read more)
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

Threshold Pharmaceuticals, Inc. (THLD): A Biotech That Investors Need To Know About

Biotech stocks can provide astronomical returns but also depressing losses. Before investing in these volatile stocks, investors need to understand the......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Thursday’s Top Upgrades (and Downgrades)

This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines......(read more)
Celgene Corporation (NASDAQ:CELG)

Two More Good Reasons to Buy Celgene Corporation (CELG)

Celgene Corporation (NASDAQ:CELG) shares have soared more than 46% so far in 2013. This booming biotech stock can’t go much higher, right? Surely......(read more)